Healthcare Equipment and Supplies
Company Overview of Nordion (Canada) Inc.
Nordion (Canada) Inc. provides medical isotopes, radiotherapeutics, and related technologies for molecular imaging. It offers molecular medicine products, including oncology, cardiology, neurology, and research products; molecular medicine services, such as discovery and pre-clinical, clinical and commercialization, and molecular imaging services; and sterilization technologies, including irradiators, and training and education services. The company serves hospitals and clinics; medical supply, biotechnology, and pharmaceutical companies; and food processors and manufacturers. Nordion (Canada) Inc. was formerly known as MDS Nordion, Inc. and changed its name to Nordion (Canada) Inc. in Novem...
447 March Road
Ottawa, ON K2K 1X8
Founded in 1946
Key Executives for Nordion (Canada) Inc.
Chief Financial Officer and Senior Vice-President
Vice President of Technology
Associate General Counsel and Secretary
Vice President of Communications
Compensation as of Fiscal Year 2014.
Nordion (Canada) Inc. Key Developments
Navidea Biopharmaceuticals, Inc. Signs Manufacturing and Supply Agreement with Nordion (Canada) Inc
May 15 13
Navidea Biopharmaceuticals Inc. announced that it has entered into an agreement with Nordion (Canada) Inc. to produce and supply (123) I-labeled NAV5001 for Navidea's late-phase clinical trials. The agreement focuses on Nordion's cGMP manufacturing and supply of NAV5001 clinical trial material to be produced at Nordion's Vancouver, British Columbia, facility. Accordingly, Nordion will radiolabel Navidea's precursor drug product with Iodine-123 to form [(123) I]NAV5001, manage the logistics and make arrangements for shipment of NAV5001 to third-party clinical trial sites on behalf of Navidea. The agreement may serve as a predecessor to a commercial supply arrangement in the future.
Lantheus Medical Imaging, Inc. Enters into Amendment No. 2 to the Molybdenum-99 Purchase & Supply Agreement with Nordion (Canada) Inc
Oct 22 12
On October 19, 2012, Lantheus Medical Imaging Inc. entered into Amendment No. 2, effective as of October 15, 2012, to the Molybdenum-99 Purchase & Supply Agreement, dated as of April 1, 2010, between the Lantheus Medical Imaging Inc. and Nordion (Canada) Inc. The Amendment extends the contract term of the Agreement from December 31, 2013 to December 31, 2015 and modifies the company's purchase requirements and supply fees. The Agreement allows for termination upon the occurrence of certain events, including, but not limited to, certain cost increases experienced by Nordion (but in such event not earlier than October 1, 2014), failure to comply with material obligations by either party, bankruptcy of either party or force majeure events.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|